pembrolizumabcapecitabinezolbetuximaboxaliplatingastric cancerNCT04249739
…st-line chemotherapy (capecitabine/oxaliplatin) with sequential pembrolizumab. CLDN18.2 expression was assessed by immunohistochemistry, and …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: zolbetuximab ×
zolbetuximab
This drug is selected. Its supporting articles are shown below.